Nectar Lifesciences Sells Narbada Industries Assets to Shree Balaji Cold Chain & Storage Services
Nectar Lifesciences Limited has completed the sale and surrender of leasehold rights in land, along with associated structures, pertaining to its wholly owned unit, Narbada Industries. The transaction was finalized with M/s Shree Balaji Cold Chain & Storage Services.The company sold the leasehold rights for a consideration of INR 9,60,00,000/- (Indian Rupees Nine Crore Sixty Lakhs only). Additionally, plant and machinery located at the premises were sold to the Purchaser for INR 1,62,00,000/- (Indian Rupees One Crore Sixty-Two Lakhs only), plus applicable taxes.
The assets being sold represent a non-core business unit, as Narbada Industries was inoperative prior to the disposal of its assets.
Details regarding the transaction and the financial status of the Narbada Industries unit are provided below:
| Metric | Details |
|---|---|
| Unit's Investment | INR 217.69 Lakhs, which constitutes 0.37% of the Company's net worth as on March 31, 2026. |
| Unit's Revenue/Income | The Business generated INR 0.00 Lacs, constituting 0.00% of the company's total revenue or income during financial year 2025-26. |
| Transaction Date | August 04, 2026 |
| Buyer Identity | M/s Shree Balaji Cold Chain & Storage Services (Purchaser). The Purchaser does not belong to the promoter group of Nectar Lifesciences Limited. |
| Transaction Status | The sale was conducted at arm's length and is not a related party transaction. |
The company confirmed that the disposal of these assets, which included both the land leasehold rights and manufacturing equipment, was a completed business event on August 04, 2026.
NECLIFE Stock Price Movement
Nectar Lifesciences Limited saw its shares slip by 1.59% on Tuesday, settling at ₹10.53 after falling ₹0.17 from the previous close of ₹10.72. The equity traded a volume of 209,897 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.